FMRI measurement of CNS responses to naloxone infusion and subsequent mild noxious thermal stimuli in healthy volunteers

被引:86
作者
Borras, MC
Becerra, L
Ploghaus, A
Gostic, JM
DaSilva, A
Gonzalez, RG
Borsook, D
机构
[1] Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston
[2] Descartes Therapeutics, Inc., Cambridge, MA 02139
关键词
D O I
10.1152/jn.00249.2003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The aims of this study were to assess the effects of a mu-opioid antagonist, naloxone, on endogenous opioid systems and to evaluate the effect of naloxone on the CNS response to mild noxious heat. Doubled-blinded experiments were performed in a cross-over design in 10 healthy male volunteers. Functional magnetic resonance imaging ( fMRI) data were collected before and during the infusion and also during thermal stimuli. Increased signal was observed in a number of cortical and subcortical brain regions for naloxone versus saline infusion. Cortical activation was induced in regions including cingulate, prefrontal cortex, and insula. Subcortical regions showing increased signal change included hippocampus and entorhinal cortex. A 46degreesC stimulus delivered to the back of the hand induced an overall increase in activation in a number of regions in the naloxone group that were not seen in the saline group ( e. g., insula, orbitofrontal cortex, thalamus, and hippocampus). These results show that naloxone, even in the absence of psychophysical effects, produces activation in several brain regions that are known to have high levels of mu-opioid receptors and may be involved in endogenous analgesia. Our study is an example of how fMRI can measure subtle changes in brain activation induced by pharmacological agents without cognitive effects.
引用
收藏
页码:2723 / 2733
页数:11
相关论文
共 81 条
  • [1] Regional brain activity changes associated with fentanyl analgesia elucidated by positron emission tomography
    Adler, LJ
    Gyulai, FE
    Diehl, DJ
    Mintun, MA
    Winter, PM
    Firestone, LL
    [J]. ANESTHESIA AND ANALGESIA, 1997, 84 (01) : 120 - 126
  • [2] Neuropharmacological dissection of placebo analgesia: Expectation-activated opioid systems versus conditioning-activated specific subsystems
    Amanzio, M
    Benedetti, F
    [J]. JOURNAL OF NEUROSCIENCE, 1999, 19 (01) : 484 - 494
  • [3] NALOXONE ATTENUATION OF THE EFFECT OF COCAINE ON REWARDING BRAIN-STIMULATION
    BAIN, GT
    KORNETSKY, C
    [J]. LIFE SCIENCES, 1987, 40 (11) : 1119 - 1125
  • [4] Reward circuitry activation by noxious thermal stimuli
    Becerra, L
    Breiter, HC
    Wise, R
    Gonzalez, RG
    Borsook, D
    [J]. NEURON, 2001, 32 (05) : 927 - 946
  • [5] BECERRA L, 2001, SOC NEUR ABSTR, V27, P507
  • [6] Becerra LR, 1999, MAGN RESON MED, V41, P1044, DOI 10.1002/(SICI)1522-2594(199905)41:5<1044::AID-MRM25>3.0.CO
  • [7] 2-M
  • [8] OPPOSITE MOTIVATIONAL EFFECTS OF ENDOGENOUS OPIOIDS IN BRAIN AND PERIPHERY
    BECHARA, A
    VANDERKOOY, D
    [J]. NATURE, 1985, 314 (6011) : 533 - 534
  • [9] Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET)
    Bencherif, B
    Fuchs, PN
    Sheth, R
    Dannals, RF
    Campbell, JN
    Frost, JJ
    [J]. PAIN, 2002, 99 (03) : 589 - 598
  • [10] BENJAMIN D, NALTREXONE REVERSES